Evaluation of Vitamin A and Zinc Supplementation on Malarial Morbidity
Evaluation of the Impact of Vitamin A and Zinc Supplementation on Malarial Morbidity in Ghana
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study was to determine whether young children receiving Vitamin A and Zinc supplements will have a lower incidence of symptomatic malaria than similar children receiving vitamin A supplements alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Mar 2009
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 27, 2013
CompletedFirst Posted
Study publicly available on registry
February 1, 2013
CompletedFebruary 1, 2013
January 1, 2013
8 months
January 27, 2013
January 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of clinical malaria attacks
6 months
Secondary Outcomes (4)
changes in weight and height/length
baseline and 6 months
changes in vitamin A and zinc nutritional status within and between the groups
baseline and 6 months
change in prevalence of anemia
baseline and 6 months
the incidence of diarrhea and pneumonia
1 time per week up to 6 months
Study Arms (2)
Vitamin A and zinc
EXPERIMENTALcombination of vitamin A and zinc supplements
Vitamin A and placebo
ACTIVE COMPARATORvitamin A with placebo
Interventions
Eligibility Criteria
You may qualify if:
- Children aged 6 - 24 months
- Child's guardian is willing to provide informed consent
- Child's family plans to remain resident in the study areas during the study period
You may not qualify if:
- Clinical evidence of vitamin A deficiency
- Severe acute malnutrition
- Severe illness
- Child aged \<6 months or \>24 months
- Receipt of vitamin A supplement within the last three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kintampo Health Research Centre, Ghanalead
- International Atomic Energy Agencycollaborator
- University of Wisconsin, Madisoncollaborator
Study Sites (1)
Kintampo Health Research Centre
Kintampo, Brong Ahafo, Ghana
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seth Owusu-Agyei, PhD
Kintampo Health Research Centre, Ghana
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2013
First Posted
February 1, 2013
Study Start
March 1, 2009
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
February 1, 2013
Record last verified: 2013-01